Background Venous percutaneous transluminal angioplasty (vPTA) in patients with multiple
sclerosis (MS) and chronic cerebrospinal venous insufficiency (CCSVI) have shown …

OBJECTIVES: Chronic cerebrospinal venous insufficiency (CCSVI) is associated with
multiple sclerosis (MS). The objective of the study was to see if percutaneous transluminal …

Importance Chronic cerebrospinal venous insufficiency (CCSVI) is characterized by
restricted venous outflow from the brain and spinal cord. Whether this condition is …

Some multiple sclerosis (MS) patients reported an improvement after percutaneous
transluminal angioplasty (PTA) for chronic cerebrospinal venous insufficiency (CCSVI) …

A randomized, double-blind, sham-controlled trial, Brave Dreams, has shown no clinical or
radiological benefit of percutaneous transluminal angioplasty (PTA) to correct chronic …

Background Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the
central nervous system with a disabling progressive course. Chronic cerebrospinal venous …

Background It has been recently hypothesised that chronic cerebrospinal venous
insufficiency (CCSVI) may be an important factor in the pathogenesis of multiple sclerosis …

Brave Dreams (Brain Venous Drainage Exploited Against Multiple Sclerosis) is likely to be
the first multicentre double blinded randomised sham controlled trial in the history of …

About ten years ago it was hoped that venous angioplasty for abnormal veins, primarily the
internal jugular veins, will be a much awaited treatment for multiple sclerosis. Yet, a majority …

Venous angioplasty in multiple sclerosis: neurological outcome at two years in a cohort of
relapsing-remitting patients - PMC Back to Top Skip to main content NIH NLM Logo Access …